Online citations, reference lists, and bibliographies.
← Back to Search

Taxol Differentially Modulates The Dynamics Of Microtubules Assembled From Unfractionated And Purified Beta-tubulin Isotypes.

W. B. Derry, L. Wilson, I. A. Khan, R. Luduena, M. Jordan
Published 1997 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Substoichiometric binding of taxol to tubulin in microtubules potently suppresses microtubule dynamics, which appears to be the most sensitive antiproliferative mechanism of taxol. To determine whether the beta-tubulin isotype composition of a microtubule can modulate sensitivity to taxol, we measured the effects of substoichiometric ratios of taxol bound to tubulin in microtubules on the dynamics of microtubules composed of purified alphabeta(II)-, alphabeta(III)-, or alphabeta(IV)-tubulin isotypes and compared the results with the effects of taxol on microtubules assembled from unfractionated tubulin. Substoichiometric ratios of bound taxol in microtubules assembled from purified beta-tubulin isotypes or unfractionated tubulin potently suppressed the shortening rates and the lengths shortened per shortening event. Correlation of the suppression of the shortening rate with the stoichiometry of bound taxol revealed that microtubules composed of purified alphabeta(II)-, alphabeta(III)-, and alphabeta(IV)-tubulin were, respectively, 1.6-, 7.4-, and 7.2-fold less sensitive to the effects of bound taxol than microtubules assembled from unfractionated tubulin. These results indicate that taxol differentially modulates microtubule dynamics depending upon the beta-tubulin isotype composition. The results are consistent with recent studies correlating taxol resistance in tumor cells with increased levels of beta(III0- and beta(IV)-tubulin expression and suggest that altered cellular expression of beta-tubulin isotypes can be an important mechanism by which tumor cells develop resistance to taxol.

This paper is referenced by
Chemoresistance in female-specific cancers and the associated anti-resistance therapies
S. Sumathi (2021)
Taxanes in cancer treatment: Activity, chemoresistance and its overcoming.
L. Mosca (2021)
Binding modes of cabazitaxel with the different human β-tubulin isotypes: DFT and MD studies
L. Zhu (2020)
In silico Investigations of the Mode of Action of Novel Colchicine Derivatives Targeting β-Tubulin Isotypes: A Search for a Selective and Specific β-III Tubulin Ligand
Lorenzo Pallante (2020)
Research progress on the source, production, and anti-cancer mechanisms of paclitaxel.
Yan-Hua Yang (2020)
Microtubule Dysfunction: A Common Feature of Neurodegenerative Diseases
A. Sferra (2020)
Mechanisms of Taxane Resistance
Sara M. Maloney (2020)
Recent Advances on Drug-Loaded Mesenchymal Stem Cells With Anti-neoplastic Agents for Targeted Treatment of Cancer
Amirhesam Babajani (2020)
Exploring the interaction of Peloruside-A with drug resistant αβII and αβIII tubulin isotypes in human ovarian carcinoma using a molecular modeling approach
Bajarang Vasant Kumbhar (2020)
Cabazitaxel exhibits more favorable molecular changes compared to other taxanes in androgen‐independent prostate cancer cells
O. Cevik (2020)
Modeling single microtubules as a colloidal system to measure the harmonic interactions between tubulin dimers in bovine brain derived versus cancer cell derived microtubules
Arooj Aslam (2020)
The Investigation of Alpha-Tubulin Differential Expression in Oligodendroglioma Brain Tumor Aiming MALDI-TOF-TOF
M. Pooladi (2019)
Over-Expression of βII-Tubulin and Especially Its Localization in Cell Nuclei Correlates with Poorer Outcomes in Colorectal Cancer
K. Ruksha (2019)
Tubulin heterogeneity regulates functions and dynamics of microtubules and plays a role in the development of drug resistance in cancer.
S. S. Prassanawar (2019)
Tubulin-VDAC Interaction: Molecular Basis for Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy
A. Rovini (2019)
Tubulin mutations in brain development disorders: Why haploinsufficiency does not explain TUBA1A tubulinopathies
Jayne Aiken (2019)
Delineating the interaction of combretastatin A-4 with αβ tubulin isotypes present in drug resistant human lung carcinoma using a molecular modeling approach
Bajarang Vasant Kumbhar (2019)
The Role of Matrix Gla Protein (MGP) Expression in Paclitaxel and Topotecan Resistant Ovarian Cancer Cell Lines
K. Sterzyńska (2018)
Interactions of β tubulin isotypes with glutathione in differentiated neuroblastoma cells subject to oxidative stress
Jiayan Guo (2018)
Paclitaxel Enhances Oncolytic Potential of Herpes Simplex Virus Type-1 in Cancer Cells
Misagh Naderi (2018)
Elucidation of the anticancer potential and tubulin isotype-specific interactions of β-sitosterol
M. Pradhan (2018)
New and Old Genes Associated with Primary and Established Responses to Paclitaxel Treatment in Ovarian Cancer Cell Lines
M. Świerczewska (2018)
β-Tubulin carboxy-terminal tails exhibit isotype-specific effects on microtubule dynamics in human gene-edited cells
Amelia L. Parker (2018)
Progesterone modulates microtubule dynamics and epiboly progression during zebrafish gastrulation.
Stephanie Eckerle (2018)
Dale P. Corkery (2018)
Genetics and Expression Profile of the Tubulin Gene Superfamily in Breast Cancer Subtypes and Its Relation to Taxane Resistance
B. Nami (2018)
Systemic epothilone D improves hindlimb function after spinal cord contusion injury in rats
Beatrice Sandner (2018)
Interaction of microtubule depolymerizing agent indanocine with different human αβ tubulin isotypes
Bajarang Vasant Kumbhar (2018)
Knowledge-guided gene prioritization reveals new insights into the mechanisms of chemoresistance
A. Emad (2017)
Quantification and expert evaluation of evidence for chemopredictive biomarkers to personalize cancer treatment
Shruti Rao (2017)
Bcl-2/Bcl-xL inhibitor ABT-737 sensitizes pancreatic ductal adenocarcinoma to paclitaxel-induced cell death.
S. Kasai (2017)
Knowledge-Guided Prioritization of Genes Determinant of Drug Response Reveals New Insights into the Mechanisms of Chemoresistance
A. Emad (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar